{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T14:11:38Z","timestamp":1780582298831,"version":"3.54.1"},"reference-count":32,"publisher":"Royal College of Psychiatrists","issue":"5","license":[{"start":{"date-parts":[[2018,1,29]],"date-time":"2018-01-29T00:00:00Z","timestamp":1517184000000},"content-version":"unspecified","delay-in-days":14699,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Psychiatry"],"published-print":{"date-parts":[[1977,11]]},"abstract":"<jats:p>A double-blind clinical trial of phenelzine and diazepam against placebo and diazepam in neurotic patients over a four-week period showed phenelzine to be superior to placebo on three rating scales in some groups of patients who completed the trial. The findings suggest that phenelzine may exert a beneficial effect on some as yet undefined features of anxiety and depression which were not revealed by a multiple regression analysis of clinical symptomatology or premorbid personality.<\/jats:p>","DOI":"10.1192\/bjp.131.5.486","type":"journal-article","created":{"date-parts":[[2008,8,12]],"date-time":"2008-08-12T22:35:43Z","timestamp":1218580543000},"page":"486-492","source":"Crossref","is-referenced-by-count":79,"title":["A Clinical Trial of Phenelzine in Anxiety Depressive and Phobic Neuroses"],"prefix":"10.1192","volume":"131","author":[{"given":"C. Q.","family":"Mountjoy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. F.","family":"Garside","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. M.","family":"Leitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"170","published-online":{"date-parts":[[2018,1,29]]},"reference":[{"key":"S0007125000094617_ref29","article-title":"Assessment of the severity of primary de-depressive illness. Wakefield self-assessment depression inventory","volume":"1","author":"Snatch","year":"1971","journal-title":"Psychological Medicine"},{"key":"S0007125000094617_ref24","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1976.01770030057008"},{"key":"S0007125000094617_ref20","article-title":"Clinical trial of the treatment of depressive illness","volume":"i","year":"1965","journal-title":"British Medical Journal"},{"key":"S0007125000094617_ref16","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.116.1.64"},{"key":"S0007125000094617_ref19","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.109.459.279"},{"key":"S0007125000094617_ref13","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.123.1.63"},{"key":"S0007125000094617_ref26","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1973.04200030093015"},{"key":"S0007125000094617_ref11","doi-asserted-by":"publisher","DOI":"10.1007\/BF00429573"},{"key":"S0007125000094617_ref5","first-page":"184","volume-title":"The Pharmacological Basis of Therapeutics","author":"Goodman","year":"1970"},{"key":"S0007125000094617_ref10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.5270.9"},{"key":"S0007125000094617_ref27","first-page":"7","article-title":"Treatment of anxiety states by antidepressant drugs","volume":"i","author":"Sargant","year":"1962","journal-title":"British Medical Journal"},{"key":"S0007125000094617_ref15","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.121.2.167"},{"key":"S0007125000094617_ref6","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.120.10.935"},{"key":"S0007125000094617_ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.2044-8341.1959.tb00467.x"},{"key":"S0007125000094617_ref25","article-title":"A controlled trial of phenelzine (Nardil) in the treatment of severe depressive illness","volume":"107","author":"Rees","year":"1961","journal-title":"Journal of Mental Science"},{"key":"S0007125000094617_ref1","volume-title":"British Pharmaceutical Codex","year":"1968"},{"key":"S0007125000094617_ref17","article-title":"the use of phenelzine sulphate (Nardil) in depression","volume":"82","author":"Levy","year":"1960","journal-title":"Canadian Medical Association Journal"},{"key":"S0007125000094617_ref18","doi-asserted-by":"publisher","DOI":"10.1007\/BF00402639"},{"key":"S0007125000094617_ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(61)92186-9"},{"key":"S0007125000094617_ref22","volume-title":"Advanced Statistical Methods in Biometric Research","author":"Rao","year":"1952"},{"key":"S0007125000094617_ref14","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.116.533.387"},{"key":"S0007125000094617_ref32","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.128.4.354"},{"key":"S0007125000094617_ref9","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.23.1.56"},{"key":"S0007125000094617_ref23","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1974.01760070050008"},{"key":"S0007125000094617_ref28","first-page":"45","volume-title":"An Introduction to Physical Methods of Treatment in Psychiatry","author":"Sargant","year":"1972"},{"key":"S0007125000094617_ref4","article-title":"Double-blind study of tranylcypromine and phenelzine in depression","volume":"25","author":"Glick","year":"1964","journal-title":"Diseases of the Nervous System"},{"key":"S0007125000094617_ref21","unstructured":"Mountjoy C. Q. & Roth M. (1975) A controlled trial of phenelzine in anxiety, depressive and phobic neuroses. Proceedings of the IXth Congress of the Collegium Internationale Neuropsychopharmacologicum. Paris 7\u201312 July 1974 (eds Boissier J. R. , Hippius H. and Pichot P. ) (Excerpta Medica International Congress Series 359), pp 778\u201381."},{"key":"S0007125000094617_ref31","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291700046419"},{"key":"S0007125000094617_ref7","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.121.2.162"},{"key":"S0007125000094617_ref12","article-title":"Acetylator status and response to phenelzine in depressed patients","volume":"i","author":"Johnstone","year":"1973","journal-title":"Lancet"},{"key":"S0007125000094617_ref3","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.112.484.309"},{"key":"S0007125000094617_ref30","doi-asserted-by":"publisher","DOI":"10.1177\/070674377301800106"}],"container-title":["British Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0007125000094617","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,27]],"date-time":"2019-05-27T20:58:11Z","timestamp":1558990691000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0007125000094617\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1977,11]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1977,11]]}},"alternative-id":["S0007125000094617"],"URL":"https:\/\/doi.org\/10.1192\/bjp.131.5.486","relation":{},"ISSN":["0007-1250","1472-1465"],"issn-type":[{"value":"0007-1250","type":"print"},{"value":"1472-1465","type":"electronic"}],"subject":[],"published":{"date-parts":[[1977,11]]}}}